+关注
罚挡煞忽
暂无个人介绍
IP属地：未知
0
关注
0
粉丝
0
主题
0
勋章
主贴
热门
罚挡煞忽
2020-09-22
不赌博复活节我就输完和都不记得是加拿大队很简单
罚挡煞忽
2020-10-07
6666
嘉和生物首日上市高开超20%，高瓴等为基石投资者
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3561389289043403","uuid":"3561389289043403","gmtCreate":1598295266061,"gmtModify":1598295266061,"name":"罚挡煞忽","pinyin":"fdshfadangshahu","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":300349892,"gmtCreate":1602050250616,"gmtModify":1703825701026,"author":{"id":"3561389289043403","authorId":"3561389289043403","name":"罚挡煞忽","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561389289043403","authorIdStr":"3561389289043403"},"themes":[],"htmlText":"6666","listText":"6666","text":"6666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/300349892","repostId":"1191082605","repostType":2,"repost":{"id":"1191082605","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1602033707,"share":"https://www.laohu8.com/m/news/1191082605?lang=&edition=full","pubTime":"2020-10-07 09:21","market":"us","language":"zh","title":"嘉和生物首日上市高开超20%，高瓴等为基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=1191082605","media":"老虎资讯综合","summary":"嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极","content":"<p>嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。<img src=\"https://static.tigerbbs.com/19034542768b06e3d7e79c7bce52f397\" tg-width=\"1500\" tg-height=\"3164\">公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。</p><p>公司称预计未来12~18个月内将持续向中国药监局和FDA提交NDA及多项临床研究新药申请。公司此次IPO价格为24港元，公开发售获1247倍认购，成为今年超购倍数第五高的新股。</p><p>公司获全球顶尖机构投资者和老牌药企入股，包括高瓴资本旗下HHJH及HM Healthcare，<a href=\"https://laohu8.com/S/600572\">康恩贝</a>旗下子公司康嘉医疗及康和医疗，淡马锡旗下的Aranda Investments等。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>嘉和生物首日上市高开超20%，高瓴等为基石投资者</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n嘉和生物首日上市高开超20%，高瓴等为基石投资者\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-10-07 09:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。<img src=\"https://static.tigerbbs.com/19034542768b06e3d7e79c7bce52f397\" tg-width=\"1500\" tg-height=\"3164\">公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。</p><p>公司称预计未来12~18个月内将持续向中国药监局和FDA提交NDA及多项临床研究新药申请。公司此次IPO价格为24港元，公开发售获1247倍认购，成为今年超购倍数第五高的新股。</p><p>公司获全球顶尖机构投资者和老牌药企入股，包括高瓴资本旗下HHJH及HM Healthcare，<a href=\"https://laohu8.com/S/600572\">康恩贝</a>旗下子公司康嘉医疗及康和医疗，淡马锡旗下的Aranda Investments等。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f1ba9d7118bf176c3c40e42b5a99126a","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191082605","content_text":"嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。公司称预计未来12~18个月内将持续向中国药监局和FDA提交NDA及多项临床研究新药申请。公司此次IPO价格为24港元，公开发售获1247倍认购，成为今年超购倍数第五高的新股。公司获全球顶尖机构投资者和老牌药企入股，包括高瓴资本旗下HHJH及HM Healthcare，康恩贝旗下子公司康嘉医疗及康和医疗，淡马锡旗下的Aranda Investments等。","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":975269599,"gmtCreate":1600710765611,"gmtModify":1703822232944,"author":{"id":"3561389289043403","authorId":"3561389289043403","name":"罚挡煞忽","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561389289043403","authorIdStr":"3561389289043403"},"themes":[],"htmlText":"不赌博复活节我就输完和都不记得是加拿大队很简单","listText":"不赌博复活节我就输完和都不记得是加拿大队很简单","text":"不赌博复活节我就输完和都不记得是加拿大队很简单","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/975269599","isVote":1,"tweetType":1,"viewCount":914,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":975269599,"gmtCreate":1600710765611,"gmtModify":1703822232944,"author":{"id":"3561389289043403","authorId":"3561389289043403","name":"罚挡煞忽","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561389289043403","authorIdStr":"3561389289043403"},"themes":[],"htmlText":"不赌博复活节我就输完和都不记得是加拿大队很简单","listText":"不赌博复活节我就输完和都不记得是加拿大队很简单","text":"不赌博复活节我就输完和都不记得是加拿大队很简单","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/975269599","isVote":1,"tweetType":1,"viewCount":914,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":300349892,"gmtCreate":1602050250616,"gmtModify":1703825701026,"author":{"id":"3561389289043403","authorId":"3561389289043403","name":"罚挡煞忽","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561389289043403","authorIdStr":"3561389289043403"},"themes":[],"htmlText":"6666","listText":"6666","text":"6666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/300349892","repostId":"1191082605","repostType":2,"repost":{"id":"1191082605","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1602033707,"share":"https://www.laohu8.com/m/news/1191082605?lang=&edition=full","pubTime":"2020-10-07 09:21","market":"us","language":"zh","title":"嘉和生物首日上市高开超20%，高瓴等为基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=1191082605","media":"老虎资讯综合","summary":"嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极","content":"<p>嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。<img src=\"https://static.tigerbbs.com/19034542768b06e3d7e79c7bce52f397\" tg-width=\"1500\" tg-height=\"3164\">公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。</p><p>公司称预计未来12~18个月内将持续向中国药监局和FDA提交NDA及多项临床研究新药申请。公司此次IPO价格为24港元，公开发售获1247倍认购，成为今年超购倍数第五高的新股。</p><p>公司获全球顶尖机构投资者和老牌药企入股，包括高瓴资本旗下HHJH及HM Healthcare，<a href=\"https://laohu8.com/S/600572\">康恩贝</a>旗下子公司康嘉医疗及康和医疗，淡马锡旗下的Aranda Investments等。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>嘉和生物首日上市高开超20%，高瓴等为基石投资者</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n嘉和生物首日上市高开超20%，高瓴等为基石投资者\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-10-07 09:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。<img src=\"https://static.tigerbbs.com/19034542768b06e3d7e79c7bce52f397\" tg-width=\"1500\" tg-height=\"3164\">公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。</p><p>公司称预计未来12~18个月内将持续向中国药监局和FDA提交NDA及多项临床研究新药申请。公司此次IPO价格为24港元，公开发售获1247倍认购，成为今年超购倍数第五高的新股。</p><p>公司获全球顶尖机构投资者和老牌药企入股，包括高瓴资本旗下HHJH及HM Healthcare，<a href=\"https://laohu8.com/S/600572\">康恩贝</a>旗下子公司康嘉医疗及康和医疗，淡马锡旗下的Aranda Investments等。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f1ba9d7118bf176c3c40e42b5a99126a","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191082605","content_text":"嘉和生物(06998.HK)首日上市高开超21%，报29.2港元，发行价24港元/股；昨日暗盘收涨38.75%。公司是一家生物制药巨头，致力于开发和商业化肿瘤学和自身免疫性药物。已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。公司称预计未来12~18个月内将持续向中国药监局和FDA提交NDA及多项临床研究新药申请。公司此次IPO价格为24港元，公开发售获1247倍认购，成为今年超购倍数第五高的新股。公司获全球顶尖机构投资者和老牌药企入股，包括高瓴资本旗下HHJH及HM Healthcare，康恩贝旗下子公司康嘉医疗及康和医疗，淡马锡旗下的Aranda Investments等。","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
